Results 141 to 150 of about 25,184 (248)

TRLS-14. PNOC022 REPORT: A COMBINATION THERAPY TRIAL USING AN ADAPTIVE PLATFORM DESIGN FOR PATIENTS WITH DIFFUSE MIDLINE GLIOMA AT INITIAL DIAGNOSIS, POST-RADIATION THERAPY, OR PROGRESSION

open access: yesNeuro-Oncology
BACKGROUND Children with diffuse midline glioma (DMG) face dismal prognoses. PNOC DMG-ACT (DMG-Adaptive Combination Trial, PNOC022) is an open-label, international trial investigating the efficacy of combination therapies for patients with DMG.
C. Kline   +38 more
semanticscholar   +1 more source

Multiblock analysis of omics and imaging data with variable selection

open access: yes, 2015
Congrès sous l’égide de la Société Française de Génie Biologique et Médical (SFGBM)National audienceSparse generalized canonical correlation analysis (SGCCA) has been proposed to combine RGCCA with an ℓ 1-penalty in a unified framework.
Frouin, Vincent   +4 more
core  

Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas. [PDF]

open access: yes, 2019
Banerjee, Anu   +44 more
core  

Adult-Onset Diffuse Midline Glioma, H3K27-Altered: A Genomics-Guided, Individualized, Multimodal Treatment Approach. [PDF]

open access: yesBrain Sci
Çelebi A   +8 more
europepmc   +1 more source

Diffuse midline glioma treated with epigenetic agent-based immunotherapy

open access: yesSignal Transduction and Targeted Therapy, 2023
Linkai Jing   +9 more
doaj   +1 more source

Photodynamic therapy for recurrent spinal diffuse midline glioma with a modest extension of overall survival: illustrative case. [PDF]

open access: yesJ Neurosurg Case Lessons
Fukumura M   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy